Investors Buy High Volume of Teladoc Health Call Options (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) saw unusually large options trading activity on Wednesday. Investors purchased 36,233 call options on the stock. This is an increase of approximately 43% compared to the typical daily volume of 25,327 call options.

Insider Buying and Selling at Teladoc Health

In related news, insider Fernando M. Rodrigues sold 4,209 shares of Teladoc Health stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $7.48, for a total transaction of $31,483.32. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Charles Divita III sold 17,138 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $7.63, for a total value of $130,762.94. Following the transaction, the chief executive officer directly owned 201,036 shares in the company, valued at $1,533,904.68. This trade represents a 7.86% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 33,288 shares of company stock worth $251,684. Company insiders own 0.58% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. IFP Advisors Inc grew its holdings in shares of Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 3,210 shares in the last quarter. Aster Capital Management DIFC Ltd grew its stake in shares of Teladoc Health by 101.1% in the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after acquiring an additional 2,425 shares in the last quarter. Bayforest Capital Ltd purchased a new stake in shares of Teladoc Health during the third quarter worth $58,000. Caitong International Asset Management Co. Ltd raised its stake in shares of Teladoc Health by 8,192.0% in the second quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider’s stock valued at $72,000 after acquiring an additional 8,192 shares in the last quarter. Finally, Ameritas Advisory Services LLC acquired a new stake in shares of Teladoc Health in the second quarter valued at $78,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on TDOC shares. BMO Capital Markets began coverage on shares of Teladoc Health in a research report on Thursday, November 13th. They set a “market perform” rating and a $8.00 price target on the stock. Bank of America reduced their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 25th. Citigroup dropped their price target on shares of Teladoc Health from $10.00 to $9.00 and set a “neutral” rating for the company in a research note on Friday, January 9th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Teladoc Health in a research report on Monday, December 29th. Finally, Evercore ISI lowered their price objective on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research report on Thursday, October 30th. Five analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $9.50.

Teladoc Health Stock Up 3.1%

Teladoc Health stock opened at $6.35 on Friday. The company has a market capitalization of $1.13 billion, a PE ratio of -4.96 and a beta of 2.04. The company has a debt-to-equity ratio of 0.71, a quick ratio of 2.60 and a current ratio of 2.70. Teladoc Health has a fifty-two week low of $6.03 and a fifty-two week high of $15.21. The firm has a 50 day moving average price of $7.17 and a 200 day moving average price of $7.70.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.05. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The business had revenue of $626.44 million during the quarter, compared to analyst estimates of $625.66 million. During the same period last year, the business posted ($0.19) earnings per share. The company’s quarterly revenue was down 2.2% on a year-over-year basis. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Research analysts expect that Teladoc Health will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.